Site-directed mutagenesis of the chemokine receptor CXCR6 suggests a novel paradigm for interactions with the ligand CXCL16

European Journal of Immunology

Volumn 38, Issue 8, 2008, Pages 2337-2350

  Petit, Sarah J ^a   Chayen, Naomi E ^b   Pease, James E ^a  

^a Faculty of Medicine   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chemokine; CXCR6; G protein coupled receptor; Molecular biology

Indexed keywords

CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; CHEMOKINE RECEPTOR CXCR; CXCL16 PROTEIN, MOUSE; CXCR6 PROTEIN, MOUSE; GRANULOCYTE CHEMOTACTIC PROTEIN 2;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; LIGAND BINDING; MEMBRANE BINDING; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; ATHEROSCLEROSIS; CHEMISTRY; CHO CELL; CRICETULUS; HAMSTER; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ATHEROSCLEROSIS; BASE SEQUENCE; CHEMOKINE CXCL6; CHO CELLS; CRICETINAE; CRICETULUS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; RECEPTORS, CXCR;

EID: 51149113105     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200838269     Document Type: Article

References (40)

1. Charo, I. F. and Ransohoff, R. M., The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 2006. 354: 610-621.
2. Matloubian, M., David, A., Engel, S., Ryan, J. E. and Cyster, J. G., A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 2000. 1: 298-304.
3. Wilbanks, A., Zondlo, S. C., Murphy, K., Mak, S., Soler, D., Langdon, P., Andrew, D. P. et al., Expression cloning of the STRL33/ BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines. J. Immunol. 2001. 166: 5145-5154.
4. Gough, P. J., Garton, K. J., Wille, P. T., Rychlewski, M., Dempsey, P. J. and Raines, E. W., A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J. Immunol. 2004. 172: 3678-3685.
5. Abel, S., Hundhausen, C., Mentlein, R., Schulte, A., Berkhout, T. A., Broadway, N., Hartmann, D. et al., The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 2004. 172: 6362-6372.
6. Shimaoka, T., Kume, N., Minami, M., Hayashida, K., Kataoka, H., Kita, T. and Yonehara, S., Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J. Biol. Chem. 2000. 275: 40663-40666.
7. Shimaoka, T., Nakayama, T., Kume, N., Takahashi, S., Yamaguchi, J., Minami, M., Hayashida, K. et al., Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J. Immunol. 2003. 171: 1647-1651.
8. Minami, M., Kume, N., Shimaoka, T., Kataoka, H., Hayashida, K., Akiyama, Y., Nagata, I. et al., Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2001. 21: 1796-1800.
9. Yamauchi, R., Tanaka, M., Kume, N.,Minami,M., Kawamoto, T., Togi, K., Shimaoka, T. et al., Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler. Thromb. Vasc. Biol. 2004. 24: 282-287.
10. Shimaoka, T., Nakayama, T., Fukumoto, N., Kume, N., Takahashi, S., Yamaguchi, J., Minami, M. et al., Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J. Leukoc. Biol. 2004. 75: 267-274.
11. Monteclaro, F. S. and Charo, I. F., The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/ MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J. Biol. Chem. 1996. 271: 19084-19092.
12. Pease, J. E., Wang, J., Ponath, P. D. and Murphy, P. M., The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1α and eotaxin binding, respectively, but a second domain is essential for receptor activation. J. Biol. Chem. 1998. 273: 19972-19976.
13. Blanpain, C., Doranz, B. J., Bondue, A., Govaerts, C., De Leener, A., Vassart, G., Doms, R.W. et al., The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J. Biol. Chem. 2003. 278: 5179-5187.
14. Govaerts, C., Bondue, A., Springael, J. Y., Olivella, M., Deupi, X., Le Poul, E., Wodak, S. J. et al., Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3. J. Biol. Chem. 2003. 278: 1892-1903.
15. Shimaoka, T., Nakayama, T., Hieshima, K., Kume, N., Fukumoto, N., Minami, M., Hayashida, K. et al., Chemokines generally exhibit scavenger receptor activity through their receptor-binding domain. J. Biol. Chem. 2004. 279: 26807-26810.
16. Farzan, M., Mirzabekov, T., Kolchinsky, P., Wyatt, R., Cayabyab, M., Gerard, N. P., Gerard, C. et al., Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 1999. 96: 667-676.
17. 2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J. Exp. Med. 2001. 194: 1661-1673.
18. Fong, A. M., Alam, S. M., Imai, T., Haribabu, B. and Patel, D. D., CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion. J. Biol. Chem. 2002. 277: 19418-19423.
19. Colvin, R. A., Campanella, G. S., Manice, L. A. and Luster, A. D., CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis. Mol. Cell. Biol. 2006. 26: 5838-5849.
20. Kuan, S. F., Byrd, J. C., Basbaum, C. and Kim, Y. S., Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. J. Biol. Chem. 1989. 264: 19271-19277.
21. Proudfoot, A. E. I., Power, C. A., Hoogerwerf, A. J., Montjovent, M.-C., Borlat, F., Offord, R. E. and Wells, T. N. C., Extension of recombinant human RAINTES by the retention of the initiating methionine produces a potent antagonist, J. Biol. Chem. 1996. 271: 2599-2603.
22. Rosenkilde, M. M. and Schwartz, T. W., GluVII:06 - a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors. Curr. Top. Med. Chem. 2006. 6: 1319-1333.
23. Cox, M. A., Jenh, C. H., Gonsiorek,W., Fine, J., Narula, S. K., Zavodny, P. J. and Hipkin, R. W., Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: Differential binding to receptor states. Mol. Pharmacol. 2001. 59: 707-715.
24. Wuttge, D. M., Zhou, X., Sheikine, Y., Wagsater, D., Stemme, V., Hedin, U., Stemme, S. et al., CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2004. 24: 750-755.
25. Galkina, E., Harry, B. L., Ludwig, A., Liehn, E. A., Sanders, J. M., Bruce, A., Weber, C. et al., CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall. Circulation 2007. 116: 1801-1811.
26. Aslanian, A. M. and Charo, I. F., Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 2006. 114: 583-590.
27. Proost, P., De Meester, I., Schols, D., Struyf, S., Lambeir, A. M., Wuyts, A., Opdenakker, G. et al., Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J. Biol. Chem. 1998. 273: 7222-7227.
28. Wise, E. L., Duchesnes, C., da Fonseca, P. C., Allen, R. A., Williams, T. J. and Pease, J. E., Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation. J. Biol. Chem. 2007. 282: 27935-27943.
29. Jensen, P. C., Nygaard, R., Thiele, S., Elder, A., Zhu, G., Kolbeck, R., Ghosh, S. et al., Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8. Mol. Pharmacol. 2007. 72: 327-340.
30. Duggal, P., An, P., Beaty, T. H., Strathdee, S. A., Farzadegan, H., Markham, R. B., Johnson, L. et al., Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans. Genes Immun. 2003. 4: 245-250.
31. Liao, F., Alkhatib, G., Peden, K.W., Sharma, G., Berger, E. A. and Farber, J. M., STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 1997. 185: 2015-2023.
32. Hundhausen, C., Schulte, A., Schulz, B., Andrzejewski, M. G., Schwarz, N., von Hundelshausen, P., Winter, U. et al., Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J. Immunol. 2007. 178: 8064-8072.
33. Schulte, A., Schulz, B., Andrzejewski, M. G., Hundhausen, C., Mletzko, S., Achilles, J., Reiss, K. et al., Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases. Biochem. Biophys. Res. Commun. 2007. 358: 233-240.
34. Haskell, C. A., Cleary, M. D. and Charo, I. F., Unique role of the chemokine domain of fractalkine in cell capture. Kinetics of receptor dissociation correlate with cell adhesion. J. Biol. Chem. 2000. 275: 34183-34189.
35. Meiser, A., Muller, A., Wise, E. L, McDonagh, E. M., Petit, S. J., Saran, N., Clark, P. C. et al., The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor. J. Immunol. 2008. 180: 6713-6724.
36. Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M. et al., Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997. 91: 521-530.
37. Fong, A.M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T. and Patel, D. D., Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 1998. 188: 1413-1419.
38. Xanthou, G., Williams, T. J. and Pease, J. E., Molecular characterization of the chemokine receptor CXCR3: Evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation. Eur. J. Immunol. 2003. 33: 2927-2936.
39. Fox, J. M., Najarro, P., Smith, G. L., Struyf, S., Proost, P. and Pease, J. E., Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist. J. Biol. Chem. 2006. 281: 36652-36661.
40. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Le Trong, I. et al., Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000. 289: 739-745.